Details for 2018819365

Up to date per 03.04.2026

Actions

Title / Product Name

VERWENDUNG VON 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMID ZUR BEHANDLUNG VON AKUTER VERSCHLIMMERUNG VON CHRONISCH OBSTRUKTIVER ATEMWEGSERKRANKUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018819365

EP Publication Number

3585382

E-Number

1410118

Language

PCT Number

GB18053590

Publication Date

01.01.2020 A

14.07.2021 B1

Registration Date

14.07.2021

AT Publication Date

15.08.2021

Application Date

11.12.2018

Registration Number

Priorities

11.12.2017

201720622

13.02.2018

201802354

IPC

A61K 31/415 20060101AFI20190621BHEP

Maximum Duration of Protection

11.12.2038

Owner

Mereo BioPharma 1 Limited1 Cavendish Place London, Greater London W1G 0QFGB

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

MACKINNON, AlastairMereo BioPharma Group plc 4th Floor, 1 Cavendish Place London Greater London W1G 0QFGB

PARKIN, JacquelineMereo BioPharma Group plc 4th Floor, 1 Cavendish Place London Greater London W1G 0QFGB

Information about Fees